Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
25
HHS Quote, Financials, Valuation and Earnings
Last price:
$5.36
Seasonality move
:
5.28%
Day range:
$5.31 - $5.42
52-week range:
$5.31 - $8.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.21x
P/B ratio:
1.87x
Volume:
31.9K
Avg. volume:
23.5K
1-year change:
-22.71%
Market cap:
$39.4M
Revenue:
$191.5M
EPS (TTM):
-$4.11
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $217.6M | $176.9M | $194.6M | $206.3M | $191.5M | |
| Revenue Growth (YoY) | -23.56% | -18.7% | 10% | 6% | -7.17% | |
| Cost of Revenues | $75.9M | $49.3M | $50.3M | $61.9M | $59.6M | |
| Gross Profit | $141.7M | $127.6M | $144.3M | $144.3M | $131.9M | |
| Gross Profit Margin | 65.12% | 72.14% | 74.17% | 69.98% | 68.89% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $146.1M | $125.2M | $127.8M | $126.5M | $118.6M | |
| Other Inc / (Exp) | -$13.4M | -$15.9M | $3.2M | $4.6M | -$11.1M | |
| Operating Expenses | $151.5M | $128.8M | $130.3M | $129.2M | $122.9M | |
| Operating Income | -$9.8M | -$1.2M | $14M | $15.1M | $9M | |
| Net Interest Expenses | $1.3M | $1.2M | $903K | $438K | -- | |
| EBT. Incl. Unusual Items | -$24.5M | -$18.3M | $16.3M | $19.3M | -$1.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.8M | -$16.6M | $1.3M | -$17.5M | -$349K | |
| Net Income to Company | -$26.3M | -$1.7M | $15M | $36.8M | -$1.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$26.3M | -$1.7M | $15M | $36.8M | -$1.6M | |
| Basic EPS (Cont. Ops) | -$4.26 | -$0.34 | $1.85 | $4.98 | -$0.21 | |
| Diluted EPS (Cont. Ops) | -$4.26 | -$0.34 | $1.76 | $4.75 | -$0.21 | |
| Weighted Average Basic Share | $6.3M | $6.5M | $6.8M | $7.1M | $7.3M | |
| Weighted Average Diluted Share | $6.3M | $6.5M | $7.2M | $7.5M | $7.3M | |
| EBITDA | -$4.5M | -$13.5M | $19.7M | $17.8M | $13.3M | |
| EBIT | -$9.8M | -$17.1M | $17.2M | $15.1M | $9M | |
| Revenue (Reported) | $217.6M | $176.9M | $194.6M | $206.3M | $191.5M | |
| Operating Income (Reported) | -$9.8M | -$1.2M | $14M | $15.1M | $9M | |
| Operating Income (Adjusted) | -$9.8M | -$17.1M | $17.2M | $15.1M | $9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $47.7M | $49.6M | $53.9M | $47.1M | $47.6M | |
| Revenue Growth (YoY) | -7.22% | 3.97% | 8.65% | -12.56% | 1.09% | |
| Cost of Revenues | $13.2M | $12.1M | $16.2M | $15.4M | $14.4M | |
| Gross Profit | $34.5M | $37.5M | $37.7M | $31.7M | $33.2M | |
| Gross Profit Margin | 72.38% | 75.51% | 69.98% | 67.36% | 69.72% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $31.6M | $31.7M | $33.4M | $27.9M | $29.4M | |
| Other Inc / (Exp) | -$3.6M | -$365K | $4.7M | -$383K | -$1.7M | |
| Operating Expenses | $32.3M | $32.3M | $33.9M | $28.8M | $30.5M | |
| Operating Income | $2.2M | $5.2M | $3.8M | $2.9M | $2.7M | |
| Net Interest Expenses | $274K | $222K | $84K | $1K | $57K | |
| EBT. Incl. Unusual Items | -$1.7M | $4.6M | $8.4M | $2.5M | $1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$53K | $172K | $1.2M | $1.9M | $868K | |
| Net Income to Company | -$1.6M | $4.4M | $7.2M | $618K | $142K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.6M | $4.4M | $7.2M | $618K | $142K | |
| Basic EPS (Cont. Ops) | -$0.27 | $0.54 | $0.87 | $0.09 | $0.02 | |
| Diluted EPS (Cont. Ops) | -$0.27 | $0.52 | $0.83 | $0.08 | $0.02 | |
| Weighted Average Basic Share | $6.5M | $6.9M | $7.1M | $7.2M | $7.3M | |
| Weighted Average Diluted Share | $6.5M | $7.2M | $7.5M | $7.3M | $7.4M | |
| EBITDA | -$659K | $5.4M | $9M | $3.9M | $3.8M | |
| EBIT | -$1.4M | $4.8M | $8.5M | $2.9M | $2.7M | |
| Revenue (Reported) | $47.7M | $49.6M | $53.9M | $47.1M | $47.6M | |
| Operating Income (Reported) | $2.2M | $5.2M | $3.8M | $2.9M | $2.7M | |
| Operating Income (Adjusted) | -$1.4M | $4.8M | $8.5M | $2.9M | $2.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $182.2M | $189.7M | $203.5M | $196.8M | $187.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $54.7M | $48.2M | $56.8M | $62.7M | $58.3M | |
| Gross Profit | $127.4M | $141.5M | $146.7M | $134.1M | $129.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $124.1M | $128.1M | $128.3M | $121M | $115.9M | |
| Other Inc / (Exp) | -$15.6M | $1.8M | $3.9M | -$5.1M | -$49.1M | |
| Operating Expenses | $128.3M | $130.8M | $130.7M | $125M | $120.2M | |
| Operating Income | -$849K | $10.7M | $16M | $9.1M | $9.2M | |
| Net Interest Expenses | $1.2M | $927K | $571K | -- | $122K | |
| EBT. Incl. Unusual Items | -$17.6M | $11.5M | $19.3M | $4M | -$40M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$12M | -$2.7M | $2.6M | -$18.2M | -$10.2M | |
| Net Income to Company | -$5.7M | $14.3M | $16.7M | $22.2M | -$29.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$5.7M | $14.3M | $16.7M | $22.2M | -$29.8M | |
| Basic EPS (Cont. Ops) | -$1.07 | $1.74 | $2.01 | $3.23 | -$4.11 | |
| Diluted EPS (Cont. Ops) | -$1.08 | $1.62 | $1.94 | $3.07 | -$4.11 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $1.2M | $15.1M | $22.2M | $7.1M | $12M | |
| EBIT | -$3M | $12.5M | $19.9M | $3.1M | $7.7M | |
| Revenue (Reported) | $182.2M | $189.7M | $203.5M | $196.8M | $187.6M | |
| Operating Income (Reported) | -$849K | $10.7M | $16M | $9.1M | $9.2M | |
| Operating Income (Adjusted) | -$3M | $12.5M | $19.9M | $3.1M | $7.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $129.8M | $142.6M | $151.5M | $142M | $138.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $36.9M | $35.9M | $42.4M | $43.2M | $41.9M | |
| Gross Profit | $92.9M | $106.7M | $109.1M | $98.8M | $96.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $92.2M | $95.1M | $95.7M | $90.2M | $87.4M | |
| Other Inc / (Exp) | -$12.5M | $5.2M | $6M | -$3.8M | -$41.7M | |
| Operating Expenses | $95.1M | $97.1M | $97.4M | $93.2M | $90.5M | |
| Operating Income | -$2.2M | $9.7M | $11.7M | $5.6M | $5.8M | |
| Net Interest Expenses | $884K | $645K | $313K | $60K | $107K | |
| EBT. Incl. Unusual Items | -$15.6M | $14.2M | $17.3M | $2M | -$36.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$12.9M | $1M | $2.3M | $1.6M | -$8.2M | |
| Net Income to Company | -$2.7M | $13.2M | $15M | $407K | -$27.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.7M | $13.2M | $15M | $407K | -$27.9M | |
| Basic EPS (Cont. Ops) | -$0.58 | $1.62 | $1.81 | $0.06 | -$3.84 | |
| Diluted EPS (Cont. Ops) | -$0.59 | $1.51 | $1.74 | $0.05 | -$3.84 | |
| Weighted Average Basic Share | $19.3M | $20.2M | $21.1M | $22M | $21.8M | |
| Weighted Average Diluted Share | $19.5M | $21M | $22.2M | $22.2M | $22M | |
| EBITDA | -$11.8M | $16.8M | $19.4M | $8.7M | $7.4M | |
| EBIT | -$14.7M | $14.9M | $17.6M | $5.6M | $4.3M | |
| Revenue (Reported) | $129.8M | $142.6M | $151.5M | $142M | $138.1M | |
| Operating Income (Reported) | -$2.2M | $9.7M | $11.7M | $5.6M | $5.8M | |
| Operating Income (Adjusted) | -$14.7M | $14.9M | $17.6M | $5.6M | $4.3M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $28.1M | $29.4M | $11.9M | $10.4M | $18.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $39M | $36M | $41.1M | $39.7M | $34.3M | |
| Inventory | $354K | -- | -- | -- | -- | |
| Prepaid Expenses | $3.4M | $9.6M | $1.9M | $2.2M | $1.9M | |
| Other Current Assets | $1.7M | $886K | $1M | $1.6M | $928K | |
| Total Current Assets | $79.3M | $86.2M | $75.4M | $66.3M | $65.2M | |
| Property Plant And Equipment | $27.1M | $30.6M | $29.9M | $29.7M | $34.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | $2.4M | $1.9M | |
| Other Intangibles | -- | -- | -- | $3.5M | $2.8M | |
| Other Long-Term Assets | $3.8M | $2.6M | $2.6M | $1.7M | $1.3M | |
| Total Assets | $110.2M | $119.5M | $107.9M | $120M | $122.8M | |
| Accounts Payable | $16.9M | $16.3M | $16.1M | $22.5M | $23.2M | |
| Accrued Expenses | $4.2M | $5.2M | $7M | $6.7M | $5.6M | |
| Current Portion Of Long-Term Debt | -- | $4.9M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $7.6M | $6.7M | $6.6M | $5.7M | $4.8M | |
| Other Current Liabilities | $2.6M | $2.9M | $2.3M | $2.9M | $9.5M | |
| Total Current Liabilities | $45.5M | $47.2M | $42.4M | $43.6M | $48.1M | |
| Long-Term Debt | $18.7M | $22.2M | $5M | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $150.2M | $162.9M | $122.9M | $101.2M | $102.9M | |
| Common Stock | $21.8M | $21.8M | $21.8M | $12.2M | $12.2M | |
| Other Common Equity Adj | -$63.1M | -$65.6M | -$53.3M | -$48.3M | -$44.1M | |
| Common Equity | -$49.7M | -$53.1M | -$24.7M | $18.8M | $19.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$40M | -$43.4M | -$15M | $18.8M | $19.9M | |
| Total Liabilities and Equity | $110.2M | $119.5M | $107.9M | $120M | $122.8M | |
| Cash and Short Terms | $28.1M | $29.4M | $11.9M | $10.4M | $18.4M | |
| Total Debt | $18.7M | $27.1M | $5M | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $29.3M | $16M | $6.9M | $13.3M | $5.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $46M | $52.6M | $45.4M | $33.3M | $33.3M | |
| Inventory | $54K | -- | -- | -- | -- | |
| Prepaid Expenses | $11.9M | $9.9M | $1.9M | $2.7M | $2.1M | |
| Other Current Assets | $1.5M | $954K | $11M | $878K | $1.5M | |
| Total Current Assets | $91.6M | $82.5M | $80.6M | $62.2M | $53.8M | |
| Property Plant And Equipment | $19.5M | $27.5M | $28.7M | $26.1M | $32.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | $2.4M | $1.9M | |
| Other Intangibles | -- | -- | -- | $3M | $2.3M | |
| Other Long-Term Assets | $3.5M | $2.5M | $1.8M | $1.3M | $734K | |
| Total Assets | $114.7M | $112.5M | $111.1M | $110.8M | $108.1M | |
| Accounts Payable | $17.6M | $16.6M | $20.8M | $18.5M | $20.9M | |
| Accrued Expenses | $5.1M | $6.3M | $5.3M | $4.9M | $4.5M | |
| Current Portion Of Long-Term Debt | $6.7M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $6.8M | $6.6M | $5.2M | $5.4M | $3.8M | |
| Other Current Liabilities | $2.9M | $2.5M | $2.9M | $2.7M | $3M | |
| Total Current Liabilities | $50M | $42.4M | $45.8M | $38.7M | $36.9M | |
| Long-Term Debt | $20.4M | $13.1M | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $153.9M | $141.1M | $114.2M | $90.3M | $87.1M | |
| Common Stock | $21.8M | $21.8M | $21.8M | $12.2M | $12.2M | |
| Other Common Equity Adj | -$60.2M | -$64.9M | -$57.1M | -$45.2M | -$16.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$39.2M | -$28.7M | -$3.1M | $20.5M | $21M | |
| Total Liabilities and Equity | $114.7M | $112.5M | $111.1M | $110.8M | $108.1M | |
| Cash and Short Terms | $29.3M | $16M | $6.9M | $13.3M | $5.9M | |
| Total Debt | $27.1M | $13.1M | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$26.3M | -$1.7M | $15M | $36.8M | -$1.6M | |
| Depreciation & Amoritzation | $5.3M | $3.6M | $2.6M | $2.7M | $4.2M | |
| Stock-Based Compensation | $1.1M | $764K | $1.5M | $2.4M | $1.4M | |
| Change in Accounts Receivable | $16.8M | -$931K | -$9.2M | $3.8M | $5.7M | |
| Change in Inventories | $94K | -- | -- | -- | -- | |
| Cash From Operations | $12.1M | -$7.8M | -$1.8M | $28.8M | $10.5M | |
| Capital Expenditures | $2.9M | $2.7M | $3M | $5.8M | $2.8M | |
| Cash Acquisitions | -- | -- | -- | -$5.8M | $500K | |
| Cash From Investing | -$2.6M | -$775K | -$2.9M | -$11.5M | -$2.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.5M | $10M | $5M | -- | -- | |
| Long-Term Debt Repaid | -$807K | -$2M | -$17.3M | -$5.2M | -$160K | |
| Repurchase of Common Stock | -$6K | -$22K | -- | -$10.5M | -$3M | |
| Other Financing Activities | -$616K | -$653K | -$795K | -$131K | -$45K | |
| Cash From Financing | $3.1M | $7.3M | -$13.4M | -$15.8M | -$3.2M | |
| Beginning Cash (CF) | $20.9M | $34.1M | $33.6M | $15.1M | $11.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $12.6M | -$1.3M | -$18.1M | $1.5M | $5M | |
| Ending Cash (CF) | $34.1M | $33.6M | $15.1M | $11.4M | $18.9M | |
| Levered Free Cash Flow | $9.2M | -$10.5M | -$4.8M | $23M | $7.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.6M | $4.4M | $7.2M | $618K | $142K | |
| Depreciation & Amoritzation | $741K | $607K | $580K | $952K | $1M | |
| Stock-Based Compensation | $272K | $330K | $926K | $161K | $368K | |
| Change in Accounts Receivable | -$7.1M | -$4.8M | -$2.3M | $503K | -$3.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$4M | -$1.2M | $12.4M | $1.5M | -$2.9M | |
| Capital Expenditures | $1.3M | $1.5M | $2.1M | $224K | $1.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.3M | -$1.5M | -$2.1M | -$222K | -$1.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -$5M | -- | -- | |
| Long-Term Debt Repaid | -$266K | -$57K | -$5M | -$49K | -- | |
| Repurchase of Common Stock | -- | $118K | -$882K | -$769K | -$163K | |
| Other Financing Activities | -$242K | -$85K | -- | -- | -- | |
| Cash From Financing | -$522K | -$314K | -$10.9M | -$818K | -$163K | |
| Beginning Cash (CF) | $36.4M | $23M | $22.8M | $14.4M | $11.5M | |
| Foreign Exchange Rate Adjustment | $1.1M | -$1.3M | -$3M | -$559K | -$8K | |
| Additions / Reductions | -$5.8M | -$3M | -$666K | $483K | -$5M | |
| Ending Cash (CF) | $31.8M | $18.7M | $19.2M | $14.3M | $6.4M | |
| Levered Free Cash Flow | -$5.3M | -$2.7M | $10.3M | $1.3M | -$4.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5.7M | $14.3M | $16.7M | $22.2M | -$29.8M | |
| Depreciation & Amoritzation | $4.2M | $2.7M | $2.4M | $4M | $4.3M | |
| Stock-Based Compensation | $925K | $1.3M | $2.2M | $1.8M | $1.9M | |
| Change in Accounts Receivable | -$5M | -$4.9M | -$1.3M | $10.6M | $1.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$8.7M | -$2.3M | $26.4M | $12.7M | -$2.7M | |
| Capital Expenditures | $2.6M | $3.8M | $6.3M | $1.5M | $4.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$438K | -$3.7M | -$6.2M | -$7.3M | -$4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$2.2M | -$4.2M | -$18.3M | -$190K | -$61K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$656K | -$522K | -$532K | -$14K | -- | |
| Cash From Financing | $7.2M | -$5M | -$15M | -$12.5M | -$411K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2M | -$11.1M | $5.2M | -$7.2M | -$7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$11.3M | -$6.1M | $20.1M | $11.1M | -$7.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2.7M | $13.2M | $15M | $407K | -$27.9M | |
| Depreciation & Amoritzation | $2.9M | $2M | $1.8M | $3.1M | $3.1M | |
| Stock-Based Compensation | $590K | $1.1M | $1.8M | $1.2M | $1.7M | |
| Change in Accounts Receivable | -$6.8M | -$10.8M | -$2.9M | $3.8M | -$287K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$11.4M | -$5.9M | $22.3M | $6.1M | -$7M | |
| Capital Expenditures | $1.4M | $2.5M | $5.7M | $1.5M | $3.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $517K | -$2.4M | -$5.7M | -$1.5M | -$3.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $10M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$2M | -$4.2M | -$5.1M | -$144K | -$45K | |
| Repurchase of Common Stock | -- | -- | -$1.2M | -$3M | -$280K | |
| Other Financing Activities | -$517K | -$386K | -$123K | -$6K | -- | |
| Cash From Financing | $7.5M | -$4.8M | -$6.4M | -$3.1M | -$325K | |
| Beginning Cash (CF) | $99.3M | $83M | $50.2M | $39.8M | $42.3M | |
| Foreign Exchange Rate Adjustment | $1.1M | -$1.7M | -$6.1M | $1.4M | -$1.9M | |
| Additions / Reductions | -$3.4M | -$13.2M | $10.1M | $1.5M | -$10.5M | |
| Ending Cash (CF) | $96.9M | $68.2M | $54.2M | $42.8M | $29.9M | |
| Levered Free Cash Flow | -$12.8M | -$8.4M | $16.5M | $4.6M | -$10.2M | |
Get HHS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HHS
Sector
P/E ratio
--
16.53x
PEG ratio
--
0.01x
P/B ratio
1.87x
1.42x
Price / LTM sales
0.21x
0.94x
Growth Metrics
HHS
Sector
Revenue growth
1.09%
-0.19%
Earnings growth
-75%
0.38%
Revenue (5-year growth)
-7.62%
1.77%
Earnings forecast
--
$0.15
Profitability
HHS
Sector
Profitability FY 2023
$131.9M
$343.9M
Return on invested capital
-146.3%
0.94%
Return on assets
-26.41%
0.07%
Return on equity
-146.3%
2.62%
Earnings Date
Last Earnings Date
Nov
14
Next Earnings Date
Mar
14
Estimated Next Earnings Date
Feb
13
Balance Sheet
HHS
Sector
Total cash
$5.9M
$115M
Short term investments
--
$67.8M
Total assets
$122.8M
$1B
Long term debt
--
$54.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
